公司資料
Lifevantage 股價、新聞與催化劑
- 股票代碼:
- LFVN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
6.84 USD (+2.24%)
收盤價
最後更新: 2026年8月24日
109M USD
市值
股價為何變動
The latest company update was “LifeVantage Declares Quarterly Dividend”. LFVN changed 0.60% and closed at $6.69 on Aug 21, 2026, indicating a relatively limited closing-price reaction to this company update.
公司概覽
Direct-Selling Wellness Company
LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants.
Nutrigenomics Positioning
The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather than conventional nutrient replacement alone.
Product Portfolio
Key offerings include the Protandim line, the MindBody GLP-1 System and products added through LoveBiome. Sales depend on consultant recruitment, customer retention and product launches across international markets.
未來催化劑
- LifeVantage’s catalysts are product sales, distributor activity, and margin discipline in consumer wellness. The company improves when its recurring consumer base stays healthy.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。